Toshiaki Tsukada
- Co-authors
- Atsushi KawakamiKeita FujikawaYojiro KawabeShigenobu NagatakiMasato InoueShin‐Ichiro TachibanaHiraku TakebeYoshio Nakai
- Topics
- Rheumatoid Arthritis Research and Therapies (5 papers)Inflammasome and immune disorders (4 papers)Eosinophilic Disorders and Syndromes (3 papers)
In The Last Decade
Toshiaki Tsukada
20 papers receiving 315 citations
Peers
Comparison fields: 5 of 48
- Rheumatology 122
- Molecular Biology 115
- Epidemiology 67
- Immunology 64
- Oncology 51
Countries citing papers authored by Toshiaki Tsukada
This map shows the geographic impact of Toshiaki Tsukada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Tsukada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Tsukada more than expected).
Fields of papers citing papers by Toshiaki Tsukada
This network shows the impact of papers produced by Toshiaki Tsukada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Tsukada. The network helps show where Toshiaki Tsukada may publish in the future.
Co-authorship network of co-authors of Toshiaki Tsukada
This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Tsukada. A scholar is included among the top collaborators of Toshiaki Tsukada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Tsukada. Toshiaki Tsukada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 9 | |
| 5 | 19 | |
| 6 | 8 | |
| 7 | 14 | |
| 8 | 4 | |
| 9 | Interleukin-6 targeting therapy in familial Mediterranean fever. | 17 |
| 10 | 12 | |
| 11 | 11 | |
| 12 | 27 | |
| 13 | 31 | |
| 14 | 1 | |
| 15 | 14 | |
| 16 | Effects of recombinant human erythropoietin therapy on blood coagulation and fibrinolysis system. | 1 |
| 17 | 52 | |
| 18 | [Untoward effects of low dose methotrexate therapy in rheumatoid arthritis]. | 3 |
| 19 | Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis. | 39 |
| 20 | 47 |
About Toshiaki Tsukada
Toshiaki Tsukada is a scholar working on Rheumatology, Nephrology and Genetics, having authored 20 papers that have together received 320 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (5 papers), Inflammasome and immune disorders (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). The work is most often cited by research in Rheumatology (122 citations), Immunology (64 citations) and Transplantation (8 citations). Toshiaki Tsukada has collaborated with scholars based in Japan and Spain. Frequent co-authors include Atsushi Kawakami, Keita Fujikawa, Yojiro Kawabe, Shigenobu Nagataki, Masato Inoue, Shin‐Ichiro Tachibana, Hiraku Takebe, Yoshio Nakai, Katsumi Eguchi and Tomoki Origuchi. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Transplantation and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.